The Fibromyalgia Treatment Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Fibromyalgia Treatment Market?
The market size for fibromyalgia treatment has seen a consistent increase in recent times. It is anticipated to rise from $2.79 billion in 2024 to $2.9 billion in 2025, registering a compound annual growth rate (CAGR) of 3.9%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Fibromyalgia Treatment Industry?
The Fibromyalgia Treatment Global Market is predicted to reach a size of $3.45 billion in 2029, expanding at a compound annual growth rate (CAGR) of 4.5%.
Download Your Free Sample of the 2025 Fibromyalgia Treatment Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Fibromyalgia Treatment Market?
The key drivers in the fibromyalgia treatment market are:
• Growth in the geriatric population globally
• Rising healthcare expenditure worldwide
• Increasing occurrence of musculoskeletal disorders
• Intensified research and development activities for better treatment options
Global Market Segmentation: Identifying Major Fibromyalgia Treatment Industry Segments
The fibromyalgia treatment market covered in this report is segmented –
1) By Type: Symptomatic Treatment, Targeted Treatment
2) By Drug Class: Antidepressants, Antiepileptics, Muscle Relaxants, Analgesics, Other Drugs
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Pre-order the 2025 Fibromyalgia Treatment Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Fibromyalgia Treatment Market?
The key trends in the fibromyalgia treatment market are:
• There is a notable trend towards the development of advanced treatment options for fibromyalgia.
• Strategic collaborations in the sector are emerging as a significant trend.
• The integration of technology into treatment methods is a rising trend.
• There is an emerging trend of innovative treatments being introduced in the market.
Who Are the Top Competitors & Leading Players in the Fibromyalgia Treatment Market?
Major companies in the fibromyalgia treatment market are:
• Pfizer Inc.
• Johnson and Johnson Services Inc.
• Roche Holding AG
• AbbVie Inc.
• Novartis AG
• Sanofi S.A.
• AstraZeneca PLC
• Abbott Laboratories
• GlaxoSmithKline PLC
• Eli Lilly and Company
• Amgen Inc.
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Regeneron Pharmaceuticals Inc.
• Mylan N.V.
• Astellas Pharma Inc.
• Biogen Inc.
• Daiichi Sankyo Co. Ltd.
• Boehringer Ingelheim International GmbH
• Sun Pharmaceutical Industries Ltd.
• Horizon Therapeutics PLC
• Endo International PLC
• Amneal Pharmaceuticals Inc.
• Zydus Lifesciences Limited
• Lupin Limited.
Regional Dominance: Which Area Leads the Global Fibromyalgia Treatment Market?
North America was the largest region in the fibromyalgia market in 2024
